| Katzung & Trevor, Basic & Clinical Pharmacology, 13th ed., chapter 6: Introduction to Autonomic Pharmacology |
Autonomic nervous system (ANS) physiology
-
•
ANS functional anatomy
-
•
ANS neurochemistry
-
•
ANS effectors
-
•
ANS reflexes
-
•
ANS regulated behaviors
|
| Rhoades & Bell, Medical Physiology: Principles for Clinical Medicine, 4th ed., chapter 8: Skeletal and Smooth Muscle |
Neural control of effectors
|
| Katzung & Trevor, Basic & Clinical Pharmacology, 13th ed., chapters 7: Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs and 8: Cholinoceptor-Blocking Drugs |
Parasympathetic pharmacology
-
•
Mechanisms of signal transduction through muscarinic and nicotinic receptors
-
•
Physiologic response to parasympathetic stimulation
-
•
Impact of receptor selectivity of parasympathomimetic and parasympatholytic agents
-
•
Mechanism of action, receptor selectivity, physiologic and adverse effects, and common uses for muscarinic receptor agonists, muscarinic receptor antagonists, acetylcholinesterase inhibitors, pralidoxime, nicotinic receptor (NN) antagonists, nicotinic receptor (NM) antagonists, and succinylcholine
|
| Katzung & Trevor, Basic & Clinical Pharmacology, 13th ed., chapters 9: Adrenoceptor Agonists & Sympathomimetic Drugs and 10: Adrenoceptor Antagonist Drugs |
Sympathetic pharmacology
-
•
Mechanisms of signal transduction through alpha- and beta-adrenergic receptors
-
•
Physiologic response to sympathetic stimulation
-
•
Impact of receptor selectivity of sympathomimetic and sympatholytic agents
-
•
Mechanism of action, receptor selectivity, physiologic and adverse effects, and common uses for alpha-adrenergic receptor agonists, alpha-adrenergic receptor antagonists, beta-adrenergic receptor agonists, beta-adrenergic receptor antagonists, and drugs affecting the uptake, synthesis, metabolism, and release of norepinephrine and epinephrine
|